Susan Audino, PhD S.A. Audino & Associates, LLC

Similar documents
ADVANCED CLINICAL CANNABINOID PROVIDER EXAM ACCP

Outcome. Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

Educating Ohio Providers On The Basics Related To Recommending Medical Marijuana. Connie J. Cerilli, APRN, FNP-C

DESCRIPTION DURATION

Ohio s Medical Marijuana Control Program

Minnesota Medical Cannabis Program. October 24, 2017

HEALTH WELLNESS COMMUNITY

Use of Cannabinoids in Medical Practice

MEDICAL CANNABIS IN MINNESOTA

SUPER SNOUTS CBD150 & CBD300 OIL FOR DOGS & CATS

MEDICAL CANNABIS IN MINNESOTA

Cannabis and the Endocannabinoid System

Key Advantages of Comprehensive Cannabis Analysis

Cannabis for RDNs (Who Don t Know their CBD from their THC!)

Medical Cannabis: A Patient Primer

Responsibility through testing THE HANDBOOK. Understanding Your Laboratory

Medical Marijuana. 1. is a plant species, variety known as hemp. 3. Tetrahydrocannabinol is an aromatic with low water solubility.

The Shifting Federal Regulation of Cannabis Products

Medical Marijuana in the Workforce. What This Is...And What It Isn t

Global Legal Cannabis Market: Size, Trends & Forecasts ( ) September 2018

OXZGEN FAQ s What is the Endocannabinoid System? What are cannabinoids? What is CBD oil?

Cannabis and What we Know. Bonnie Schnittker RN PHN Public Health Nurse October 20, 2017

CBD and Your Health.

Medical Cannabis Then and Now. Jeffrey Skell, PhD

Susan Allen-Evenson Hosts: Laura Lagano, MS, RDN, CDN Prepare for the Next Level: Incorporating Holistic Cannabis in the Nutrition Practice

Certi cate of Analysis

Certi cate of Analysis

Certi cate of Analysis

Certi cate of Analysis

Certi cate of Analysis

Certi cate of Analysis

Certi cate of Analysis

Curious about Cannabis? Navigating the cannabis landscape in Pennsylvania LINDSEY MESTON, PHARMD ASHLEY FIRM, PHARMD

Quality Assessments for an Organically-Complex Drug - Part 1 Background and the Chemometrics Role

INITIAL PATIENT INTAKE FORM

PATIENT INTAKE FORM. Name: Address: Town: State: Zip Code: MMJ Card #: Exp. Date: Drivers License #: Exp. Date: Home Phone: Cell:

The Scientific Side of Medical Marijuana

Weeding out the myths on Medical Cannabis

Certi cate of Analysis

Certi cate of Analysis

Understanding Hemp Extracts and CBD Oil. Quality assurance, product selection, and serving size tracking.

MINNESOTA S MEDICAL CANNABIS PROGRAM

Research on Cannabis and PD: Is there any evidence?

Be it enacted by the People of the State of Illinois,

Cannabis in the treatment of Autism:

Substitute HB 523 Outline

(THC) Delta9-tetrahydrocannabinol:

Certi cate of Analysis

Certi cate of Analysis

Medicinal Marihuana Science, Redefined

Medical Marijuana Consent Form

The Return of Medicinal Cannabis

MARIJUANA in MEDICAL CARE READY or RISKY. HINDI MERMELSTEIN, MD FAPM Beth Israel Medical Center, NYC Dec

Certi cate of Analysis

THE COMPLETE CBD GUIDE

AZ s Medical Marijuana Law Overview and Considerations. Ryan Hurley Partner, Chair of MMJ Dept. Rose Law Group pc

Cannabis & Hemp therapeutic solutions

Certi cate of Analysis

The Department must establish a minimum of three regions within the state for the purpose of granting permits to growers/processors and dispensaries.

Certi cate of Analysis

Certi cate of Analysis

Certi cate of Analysis

Certi cate of Analysis

9/13/2017. Marijuana and the Brain Matthew Wong, MD Assistant Professor, Department of Neurology, Epilepsy Section. Disclosures.

Leading a budding industry into the future

Medical Marijuana Update Chris Belletieri, DO

Medical Cannabis Program. Dr. Maureen Small Co Medical Director Andrea Sundberg Program Coordinator

Certi cate of Analysis

Extraction, Isolation and Analysis of Cannabis Extract and Preparation

Medical Cannabis. Danial Schecter, MD, CCFP. Vocational Rehabilitation Association November 7th, Executive Director Cannabinoid Medical Clinic

The Company. Beyond Pioneering

MEDICAL CANNABIS PATIENT COUNSELING. Krissy Bernazani, RPh Clinical Director Zen Leaf

Weeding Through the Workplace Impact of Medical Marijuana

CBD Oil: Anxiety Aid & Much More

Medical Marijuana: Current Policies and Consideration. By Michael Bertaut Healthcare Economist, BCBSLA 2019

Dr. Hagit Marchaim, Regulatory Affairs & Drug Development Consulting - HMC

Medical Marijuana: The Move to Schedule II

INNOVATING WELLNESS RELIEF

Brian C. Smith, Ph.D. Chief Technical Officer Big Sur Scientific (508)

James Donaldson CEO and Executive Director

Cannabis and Cannabinoids: Review of Existing and Potential Therapeutic Applications in Oncology

INFUSED II LABORATORY REPORT

Ultimate Guide: Everything You Need To Know Before Buying CBD Hemp Oil

Scottsdale Certification Center Health History Questionnaire. Name Gender M / F Date. Date of Birth / / Phone Ht: ft in Wt. Residential Address

July 15 TH, ANDREW MEDVEDOVSKY, M.D. Board Certified Neurologist & Pain Medicine Specialist Director New Jersey Alternative Medicine

1 Hartford Square, New Britain, CT Armen Paronyan, CEO Jason Kang, Founding Member Jose Zavaleta, Lab Director

AGENDA. 9:00 Sign-in and introductions 9:15 Marijuana 10:30 Break 10:45 Opioid Prevention 11:30 Discussion & Wrap-Up

VENDOR RULES INTRODUCTION SAFETY FIRST APPOINTMENT HOURS

A Primer About Cannabidiol And The Benefits of CBD

Research: Medical Cannabis

CDHA 2016 Fall Symposium. Speaker Handout Files. For registered attendees only

Medical vs Recreational Use of Cannabis. 11 th December 2017

Improved Gas Chromatographic Quantification of Acidic and Neutral Cannabinoids

Legalized Marijuana: Uses, Misuses & Abuses. Disclosures. Objectives. Kennon Heard University of Colorado SOM Dept Of Emergency Medicine

Cannabis Potency, Dosing & Safety by MCR Labs

Pennsylvania s Medical Marijuana Act and the Creation of a New Protected Class of Employees. Agenda

Medical Cannabis MATT WEBSTER DO, MS

Steven G. Kinsey, PhD Associate Professor, Department of Psychology West Virginia University

GW Pharmaceuticals plc. Investor Presentation August 2014

Transcription:

Cachexia, Cancer, Chronic Pain, Epilepsy, Glaucoma, HIV, AIDS, Multiple Sclerosis, Nausea, ALS, Crohn s, Hepatitis C, Anorexia, Arthritis, Migraine, Parkinson s, Damage to the Nervous Tissue of the Spinal Cord with Objective Neurological Indication of Intractable Spasticity, PTSD, Traumatic Brain Injury, Use of Azidothymidine, Tourette Syndrome, Lupus, Chemotherapy or Radiotherapy, Reflex Sympathetic Dystrophy, Neurofibromatosis, Arnold-Chiari Malformation, Hydrocephalus, Residual Limb Pain, Terminal Illness with a Life Expectancy Under One Year, Hospice Care, Huntington s, Chronic Renal Failure If you or someone you know suffers or endures any one of these, you have an interest in the medical marijuana industry and recognize the importance of analytical testing. Stakeholder Panel on Strategic Food Analytical Methods: Background and Fitness for Purpose for CANNABIS Susan Audino, PhD S.A. Audino & Associates, LLC AOAC International Dallas, TX September 18, 2016

Cannabis Advisory Panel Susan Audino, Chair GW Pharmaceuticals Peter Gibson SC Laboratories Josh Wurzer SCIEX Paul Winkler SPEX Patricia Atkins Sigma Aldrich Jennifer Claus CEM Bob Lockerman Medical Cannabis Background Medicinal Marijuana is legal in 24 states & D.C. Schedule I Drug = No medicinal value Federal Prohibition States are self-regulated Several require analytical testing Potency Pesticide Residue Microbial Solvent Residue

Medical Cannabis Background The PLANT Highly complex herb; heterogeneous within and between More than 400 constituents approximately 114 are phyto cannabinoids which are naturally occurring cannabinoids About a dozen of these have demonstrated medicinal value Only one is psychoactive More than 29 flavonoids The CANNABINOIDS All contain carboxylic acid groups that are kicked off with heat Interest in both acid and neutral compounds Cannabinoid acids are devoid of psychotropic effects Some Medicinal Applications & Benefits Decreases intra-ocular pressure Glaucoma Provides some abatement of severe anxiety PTSD Reduces seizure activity; in some cases from 300 to 1/week Provides suppression of muscle spasms Multiple Sclerosis Provides calming effect on the immune system - Lupus

How does this work? Endocannabinoid Receptor System (ECS) Discovered in mid-1990s and found in every living being except insects. Two known receptors (more expected on the horizon) CB1 and CB2 CB1: predominantly found in the brain; helps modulate and moderate pain CB2: primarily found in the immune system; has anti-inflammatory properties

Cannabis Dosing Inhalation: Smoke, Vapors Transdermal: Patches, Salves Oral: Edibles, Tinctures Most challenging: Edibles Hottest Topic of the Day: Pesticide Residues

Food Items & Label Claims

Significance If edibles are the vehicle for dosing, then knowing what and how much of the analyte is present becomes the single most critical factor. Reliable and Effective Testing is IMPERATIVE. What does this mean? Producers are making potency and constituent claims. How can they be challenged? Consumer Safety

Analytical Challenges COMPLEX MATRIX Raw Plant material Trim Bud Flower Stem Composite Heterogeneity Within a single plant Between different plants same strain or different strains Analytical Challenges Food Matrices when is cannabis introduced into the product? Beginning of process Mid-Process Topical/surface - What is the end product? - And what/if any loss in cannabis is realized?

Significance and Implications The LACK of consensus methods Inadequate testing Inappropriate testing Non-Reproducibility Inherently unreliable Constant battle between growers and test labs SAMPLE SIZE Instrumentation better testing costs more in $$ and time Balancing scientific acumen with business General Analytical Needs Potency THC, THCA, THCV CBD, CBDA, CBDV CBG CBN Pesticide Residues Matrices Raw Extracts Edibles

General Analytical Needs Consensus methods Validated Statistically Sound Reproducible Repeatable Reliable Robust Correct Technology Affordable to consumers Traditional methodology Challenges Federal Prohibition Matrix Effects Fiscal concerns: Sample Size Instrumentation Analyst skill set Turn-around-time Qualitative vs. Quantitative Pesticides which ones??

General Methods: US Herbal Pharmacopoeia Monograph No standardized methods GC -FID: quantitation of phytocannabinoids ICP-MS: Metals (Ar, Cd, Cr, Pb, Hg) Methods are outlined but seem to lack validation data. GC/HPLC: Pesticides - Refers to FDA Pesticide Analytical Manual TLC No /Inconsistent Regulatory Guidance NO Federal Guidance: FDA EPA USDA States are self regulating and developing their own sets of standards and requirements ISO/IEC 17025 TNI Other None State Oversight DOH Agriculture Commissions Other

Sense of Urgency In the interest of consumer safety, an advisory panel has formed and is committed to developing consensus methods for specific use in the cannabis industry. The field is large; our initial objective(s) is to systematically target most urgent needs which may include: Determining the most cost efficient and scientifically sound sample preparation method(s) Determining potency of the most significant phyto-cannabinoids For example: THC, THCA, THCV, CBD, CBDA, CBDV, CBN, CBG Determining pesticide residues Determining solvent residues Proposed Fitness for Purpose ~ Standard Methods Performance Requirements (SMPRs) for quantitative methods for various measurements of cannabinoids in raw materials and extracts ~

Next Steps Form Working Group(s) of interested and capable personnel with commitment to solve this problem. Advantages Close work with highly reputable analysts Be a trend setter! Be among the first to establish critical methods for the benefit of consumer safety Susan Audino,PhD QUESTIONS & DISCUSSION Susan Audino@gmail Susan.Audino@gmail.com 410.459.9208